• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Compute Health Acquisition Corp.

    2/14/22 4:35:16 PM ET
    $CPUH
    Blank Checks
    Finance
    Get the next $CPUH alert in real time by email
    SC 13G 1 ea155623-13gsponsor_compute.htm SCHEDULE 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    (Amendment No. )*

     

    Under the Securities Exchange Act of 1934

     

    Compute Health Acquisition Corp.

    (Name of Issuer)

     

    Class A Common Stock, par value $0.0001 per share

    (Titles of Class of Securities)

     

    204833107

    (CUSIP Number)

     

    December 31, 2021

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out of a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    1

    NAME OF REPORTING PERSON

     

    Compute Health Sponsor LLC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY 

     

    4 CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6 SHARED VOTING POWER

     

    21,442,500 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    21,442,500 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    21,442,500 (1)

    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐


    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    19.9% (2)

    12

    TYPE OF REPORTING PERSON

     

    OO

     

    (1)Reflects 21,442,500 shares of Compute Health Acquisition Corp. (the “Company”) common stock, par value $0.0001 per share (“Class A Common Stock”), issuable upon conversion of 21,442,500 shares of the Company’s Class B common stock, par value $0.0001 per share (“Class B Common Stock”), held directly by Compute Health Sponsor LLC (the “Sponsor”). The Class B Common Stock will automatically convert into Class A Common Stock at the time of the Company’s initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment.

     

    (2)The calculation assumes that there is a total of 107,812,500 shares of Class A Common Stock outstanding, which is the sum of (i) the 86,250,000 shares of Class A Common Stock outstanding as of November 16, 2021, as reported in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021 (the “Report”), and (ii) the 21,562,500 shares of Class A Common Stock issuable upon conversion of the Class B Common Stock held by the Sponsor.

     

    2

     

     

    1

    NAME OF REPORTING PERSON

     

    Joshua Fink

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY 

     

    4 CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6 SHARED VOTING POWER

     

    21,442,500 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    21,442,500 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    21,442,500 (1)

    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    19.9% (2)

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Reflects 21,442,500 shares of Class A Common Stock issuable upon conversion of 21,442,500 shares of Class B Common Stock held by the Sponsor. The Class B Common Stock will automatically convert into Class A Common Stock at the time of the Company’s initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. The Sponsor is managed by each of Joshua Fink, Omar Ishrak, and Jean Nehmé. As a result of the foregoing, Mr. Fink may be deemed to beneficially own the shares held by the Sponsor.

     

    (2)The calculation assumes that there is a total of 107,812,500 shares of Class A Common Stock outstanding, which is the sum of (i) the 86,250,000 shares of Class A Common Stock outstanding as of November 16, 2021, as reported in the Report, and (ii) the 21,562,500 shares of Class A Common Stock issuable upon conversion of the Class B Common Stock held by the Sponsor.

     

    3

     

     

    1

    NAME OF REPORTING PERSON

     

    Omar Ishrak

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY 

     

    4 CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6 SHARED VOTING POWER

     

    21,442,500 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    21,442,500 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    21,442,500 (1)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    19.9% (2)

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Reflects 21,442,500 shares of Class A Common Stock issuable upon conversion of 21,442,500 shares of Class B Common Stock held by the Sponsor. The Class B Common Stock will automatically convert into Class A Common Stock at the time of the Company’s initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. The Sponsor is managed by each of Joshua Fink, Omar Ishrak, and Jean Nehmé. As a result of the foregoing, Dr. Ishrak may be deemed to beneficially own the shares held by the Sponsor.

     

    (2)The calculation assumes that there is a total of 107,812,500 shares of Class A Common Stock outstanding, which is the sum of (i) the 86,250,000 shares of Class A Common Stock outstanding as of November 18, 2021, as reported in the Report, and (ii) the 21,562,500 shares of Class A Common Stock issuable upon conversion of the Class B Common Stock held by the Sponsor.

     

    4

     

     

    1

    NAME OF REPORTING PERSON

     

    Jean Nehmé

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY 

     

    4 CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United Kingdom

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

    5

    SOLE VOTING POWER

     

    0

    6 SHARED VOTING POWER

     

    21,442,500 (1)

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    21,442,500 (1)

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    21,442,500 (1)

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ☐

      

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

    19.9% (2)

    12

    TYPE OF REPORTING PERSON

     

    IN

     

    (1)Reflects 21,442,500 shares of Class A Common Stock issuable upon conversion of 21,442,500 shares of Class B Common Stock held by the Sponsor. The Class B Common Stock will automatically convert into Class A Common Stock at the time of the Company’s initial business combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. The Sponsor is managed by each of Joshua Fink, Omar Ishrak, and Jean Nehmé. As a result of the foregoing, Dr. Nehmé may be deemed to beneficially own the shares held by the Sponsor.

     

    (2)The calculation assumes that there is a total of 107,812,500 shares of Class A Common Stock outstanding, which is the sum of (i) the 86,250,000 shares of Class A Common Stock outstanding as of November 18, 2021, as reported in the Report, and (ii) the 21,562,500 shares of Class A Common Stock issuable upon conversion of the Class B Common Stock held by the Sponsor.

     

    5

     

     

    Item 1(a).Name of Issuer:


    Compute Health Acquisition Corp.

     

    Item 1(b).Address of Issuer’s Principal Executive Offices:

     

    1105 North Market Street, 4th Floor, Wilmington, DE 19890.

     

    Item 2(a).Name of Person Filing:

     

    This statement is being filed jointly pursuant to §240.13d-1(k)(1) on behalf of each of the following persons (collectively, the “Reporting Persons”):

     

    1. Compute Health Sponsor LLC

    2. Joshua Fink

    3. Omar Ishrak

    4. Jean Nehmé

     

    Item 2(b).Address of Principal Business Office or, if none, Residence:

     

    The principal business address of each of the Reporting Persons is as follows:

     

    1105 North Market Street, 4th Floor, Wilmington, DE 19890.

     

    Item 2(c).Citizenship:

     

    See responses to Item 4 on each cover page.

     

    Item 2(d).Titles of Classes of Securities:

     

    Class A Common Stock, par value $0.0001 per share

     

    Item 2(e).CUSIP Number:

     

    204833107

     

    Item 3.If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) ☐ Broker or dealer registered under Section 15 of the Exchange Act (15 U.S.C. 78o).
           
      (b) ☐ Bank as defined in Section 3(a)(6) of the Exchange Act (15 U.S.C. 78c).
           
      (c) ☐ Insurance company as defined in Section 3(a)(19) of the Exchange Act (15 U.S.C. 78c).
           
      (d) ☐ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) ☐ Investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
           
      (f) ☐ Employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
           
      (g) ☐ Parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
           
      (h) ☐ Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
           
      (i) ☐ Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
           
      (j) ☐ Non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).
           
      (k) ☐ Group in accordance with §240.13d-1(b)(1)(ii)(K).
       
    If filing as a non-U.S. institution in accordance with §240. 13d-1(b)(1)(ii)(J), please specify the type of institution:

     

    6

     

     

    Item 4.Ownership  

     

    (a)Amount beneficially owned:

     

    See response to Item 9 on each cover page.

     

    (b)Percent of class:

     

    See response to Item 11 on each cover page.

     

    (c)Number of shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote:

     

    See response to Item 5 on each cover page.

     

    (ii) Shared power to vote or to direct the vote:

     

    See response to Item 6 on each cover page.

     

    (iii) Sole power to dispose or to direct the disposition of:

     

    See response to Item 7 on each cover page.

     

    (iv) Shared power to dispose or to direct the disposition of:

     

    See response to Item 8 on each cover page.

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item 6.Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.  

     

    Not Applicable.

     

    Item 8.Identification and Classification of Members of the Group.

     

    Not Applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not Applicable.

     

    Item 10.Certification.  

     

    Not Applicable.

     

    7

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2022

     

      Compute Health Sponsor LLC
       
      By: /s/ Joshua Fink
        Name: Joshua Fink
        Title: Co-Chief Executive Officer
         
      Joshua Fink
      /s/ Joshua Fink
         
      Omar Ishrak
      /s/ Omar Ishrak
       
      Jean Nehmé
      /s/ Jean Nehmé

     

    8

     

     

    Exhibit Index

     

    Exhibit 1   Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.

     

     

    9

     

    Get the next $CPUH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CPUH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CPUH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Allurion Debuts as a Publicly Traded Company on the NYSE

    Allurion to commence trading on August 2, 2023 on the New York Stock Exchange under ticker symbol "ALUR" Business combination with Compute Health Acquisition Corp. completed on August 1, 2023 Net proceeds from transaction total approximately $100 million, significantly higher than the $70 million minimum closing condition Allurion Technologies, Inc. ("Allurion"), a company dedicated to ending obesity, today announced the completion of its previously announced business combination (the "Business Combination") with Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH), a publicly traded special purpose acquisition company. Allurion is expected to commence trading of its common

    8/1/23 4:05:00 PM ET
    $CPUH
    $ESTA
    Blank Checks
    Finance
    Industrial Specialties
    Health Care

    Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion

    Allurion Technologies, Inc. ("Allurion"), a company dedicated to ending obesity, and Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH) today announced that Compute Health's stockholders have approved all proposals related to the previously announced business combination (the "Business Combination") between Compute Health and Allurion at a special meeting of Compute Health's stockholders held on July 28, 2023. Approximately 99.8% of the votes cast on the Business Combination proposals by holders of Compute Health's common stock, representing approximately 87.7% of Compute Health's outstanding common stock, voted to approve the Business Combination, including approximately 58.2%

    7/28/23 4:05:00 PM ET
    $CPUH
    Blank Checks
    Finance

    Compute Health Acquisition Corp. Warrant Holders Hold Special Meeting

    Warrant Holders Approve Warrant Agreement Amendment Compute Health Acquisition Corp. ("Compute Health") (NYSE:CPUH, CPUH WS, CPUH.U))) today announced that at a special meeting of Compute Health's warrant holders held today (the "Warrant Holder Meeting"), the previously announced proposal to amend the warrant agreement that governs the outstanding warrants of Compute Health (the "Warrant Amendment") was approved by its warrant holders. Approximately 89% of the votes cast at the Warrant Holder Meeting, including votes cast by holders of approximately 55% of Compute Health's outstanding public warrants, voted to approve the Warrant Amendment. The Warrant Holder Meeting was held, and the W

    7/26/23 4:05:00 PM ET
    $CPUH
    Blank Checks
    Finance

    $CPUH
    SEC Filings

    View All

    SEC Form 15-12G filed by Compute Health Acquisition Corp.

    15-12G - Compute Health Acquisition Corp. (0001828608) (Filer)

    8/14/23 4:53:57 PM ET
    $CPUH
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Compute Health Acquisition Corp.

    25-NSE - Compute Health Acquisition Corp. (0001828608) (Subject)

    8/2/23 9:56:22 AM ET
    $CPUH
    Blank Checks
    Finance

    SEC Form DEFA14A filed by Compute Health Acquisition Corp.

    DEFA14A - Compute Health Acquisition Corp. (0001828608) (Filer)

    7/28/23 5:20:14 PM ET
    $CPUH
    Blank Checks
    Finance

    $CPUH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4: Compute Health Sponsor Llc was granted 2,088,327 shares and returned 2,088,327 shares to the company (Amendment)

    4/A - Compute Health Acquisition Corp. (0001828608) (Issuer)

    8/3/23 8:26:26 PM ET
    $CPUH
    Blank Checks
    Finance

    SEC Form 4: Harsh Michael was granted 21,120 shares and returned 31,120 shares to the company, closing all direct ownership in the company

    4 - Compute Health Acquisition Corp. (0001828608) (Issuer)

    8/3/23 4:39:05 PM ET
    $CPUH
    Blank Checks
    Finance

    SEC Form 4: Watanabe Gwendolyn A was granted 21,120 shares and returned 21,120 shares to the company

    4 - Compute Health Acquisition Corp. (0001828608) (Issuer)

    8/3/23 4:39:25 PM ET
    $CPUH
    Blank Checks
    Finance

    $CPUH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Compute Health Acquisition Corp. (Amendment)

    SC 13G/A - Compute Health Acquisition Corp. (0001828608) (Subject)

    2/14/23 11:24:05 AM ET
    $CPUH
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Compute Health Acquisition Corp. (Amendment)

    SC 13G/A - Compute Health Acquisition Corp. (0001828608) (Subject)

    2/10/23 2:05:45 PM ET
    $CPUH
    Blank Checks
    Finance

    SEC Form SC 13G filed by Compute Health Acquisition Corp.

    SC 13G - Compute Health Acquisition Corp. (0001828608) (Subject)

    2/14/22 4:35:16 PM ET
    $CPUH
    Blank Checks
    Finance